Margin to Depth of Invasion Ratio: A Significant Predictor of Survival in Patients With Oral Cancer.
Journal
JCO global oncology
ISSN: 2687-8941
Titre abrégé: JCO Glob Oncol
Pays: United States
ID NLM: 101760170
Informations de publication
Date de publication:
08 2023
08 2023
Historique:
medline:
14
8
2023
pubmed:
10
8
2023
entrez:
10
8
2023
Statut:
ppublish
Résumé
A common definition of a clear margin (≥5 mm) in oral squamous cell carcinoma (OSCC) for all stages is a subject of controversy. Studies have shown that even 1- and 2-mm margins are adequate, and few studies have identified dynamic resection margin as a criterion. We aimed to study the margin to depth of invasion ratio (MDR), margin to tumor thickness ratio (MTR), and margin to tumor size ratio (MSR) as prognostic markers for survival. Notably, to our knowledge, this is the first study to evaluate the role of MDR in OSCC. A prospectively maintained head and neck cancer database was analyzed from January 2017 to February 2023. The MDR, MTR, and MSR were calculated for each patient. Survival outcomes were analyzed using the Cox proportional model and the Kaplan-Meier method. Akaike's information criterion (AIC) and Bayesian information criterion (BIC) were used to compare different ratio models. X-tiles software was used to identify the optimal cutoff value of MDR. Two hundred eighty patients in the database were assessed, of which 123 eligible patients were enrolled in the study. MDR was an independent predictor of disease-free survival (DFS) on multivariate analysis. The MDR model had the lowest values on AIC and BIC analyses. A cutoff value of 0.5 for MDR showed a significant correlation with DFS and overall survival. MDR was the best predictor of recurrence of all the three ratios studied. The minimum safe surgical margin can be calculated by multiplying the depth of invasion by 0.5. This study signifies the role of dynamic resection margin criteria on the basis of MDR in defining clear margins.
Identifiants
pubmed: 37561980
doi: 10.1200/GO.23.00144
pmc: PMC10581600
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2300144Références
Oral Oncol. 2020 Nov;110:104913
pubmed: 32711167
CA Cancer J Clin. 2017 Mar;67(2):122-137
pubmed: 28128848
Oral Oncol. 2020 Dec;111:104938
pubmed: 32739791
Ann Oncol. 2019 Dec 1;30(12):1884-1901
pubmed: 31566661
Lancet Oncol. 2019 Oct;20(10):1349-1359
pubmed: 31416685
Cancer. 2009 Apr 1;115(7):1489-97
pubmed: 19197973
Clin Cancer Res. 2004 Nov 1;10(21):7252-9
pubmed: 15534099
Am J Surg. 2000 Aug;180(2):139-43
pubmed: 11044531
J Clin Oncol. 2022 Jan 10;40(2):138-149
pubmed: 34699271
Cancers (Basel). 2022 Nov 21;14(22):
pubmed: 36428794
Oral Oncol. 2021 Aug;119:105358
pubmed: 34049257
Front Oncol. 2020 Feb 04;9:1571
pubmed: 32117789
J Otolaryngol Head Neck Surg. 2022 Oct 4;51(1):38
pubmed: 36195903
J Otolaryngol Head Neck Surg. 2016 Nov 22;45(1):61
pubmed: 27876067
Am J Surg Pathol. 2005 Feb;29(2):167-78
pubmed: 15644773
Eur Arch Otorhinolaryngol. 2020 Apr;277(4):1155-1165
pubmed: 31897720
J Surg Oncol. 2021 Mar;123(4):872-880
pubmed: 33497489
Clin Otolaryngol. 2019 Jan;44(1):63-69
pubmed: 30296003
Oral Oncol. 2016 Apr;55:49-54
pubmed: 26861256
JAMA Otolaryngol Head Neck Surg. 2014 Dec;140(12):1138-48
pubmed: 25075712